Medical Education and the Affordable Care Act

Posted by Fuld + Company on Jan 28, 2016 10:32:17 AM

Ken Sawka   | Jacob Golbitz 

Perhaps it was inevitable. Kaiser Permanente, the California-based health system that integrates health insurance with its own hospitals and clinics, last month announced that it would open its own medical school in the state in 2019. 

The move underscores two factors that have bedeviled healthcare reform in the United States before and after the passage of the Affordable Care Act in 2010 – a forecasted shortage of physicians in the United States, and the failure of traditional medical education to keep pace with the training required to enable physicians to provide healthcare in an integrated, risk-based system.

Read More

Topics: Competitive Intelligence, Innovation, Market Analysis, Healthcare, Life Sciences

Is the Chevrolet Bolt a Tesla-Killer?

Posted by Christopher Dent on Jan 14, 2016 1:34:32 PM

The Chevrolet Bolt

Tesla has been synonymous with electric cars for nearly a decade. Sleek, forward-thinking, high-end: that’s the Tesla we know today. Still, from the inception of the Tesla Roadster, CEO Elon Musk has insisted that Tesla’s strategic end-goal is to one day create a “super affordable electric vehicle with mass market appeal.  

That day has finally come. But it’s not Tesla holding the prize. 

Read More

Topics: Brand Insights, Market Analysis, Product Positioning, Competitive Strategy

Fuld + Company and Agromeris Partner to Expand Services for Food and Agriculture Industry

Posted by Fuld + Company on Dec 14, 2015 8:00:00 AM


FOR IMMEDIATE RELEASE

BOSTON, MA, December 14, 2015 -- Fuld + Company, a competitive intelligence, strategy, and consulting firm, announced that it has signed a memorandum of understanding with Agromeris, a food and agriculture consulting firm.

The partnership provides Agromeris with methodological expertise and research capacity, drawn from Fuld + Company's 35+ years of experience. Agromeris brings to the partnership 30 years of deep domain expertise across the entire food production value chain, from field to table.

Read More

Topics: Competitive Intelligence, Consumer Goods, Fuld + Company, Manufacturing/Industrial, Market Analysis, Scenario Analysis, Product Positioning, Competitive Strategy

Five Things Lockheed Martin Needs Sikorsky to Do

Posted by Christopher Dent on Dec 3, 2015 8:00:00 AM

On November 6th, United Technologies Corporation (UTC) closed the sale of its Sikorsky aerospace unit to defense giant Lockheed Martin for $9B.  Does this acquisition improve the strategic position of both companies or will Sikorsky prove to be a white elephant?

Read More

Topics: Brand Insights, Market Analysis, Merger and Acquisition, Competitive Strategy

New White Paper! Exploring New Markets to Boost Plant Capacity Utilization

Posted by Fuld + Company on Nov 30, 2015 9:28:31 AM


While our micro case studies have proven popular, sometimes an engagement warrants a deeper look.

For instance, determining which markets to enter is a critical decision. Syndicated research reports can't provide insights specifically tailored to a single organization's objectives and capabilities.

Read More

Topics: Consumer Goods, Fuld + Company, Market Analysis, New Market Entry

New White Paper! New Strategies for Health Care Industry Convergence

Posted by Fuld + Company on Nov 23, 2015 8:00:00 AM


Consumer retail, enterprise IT, consumer electronics, health insurance, and health care delivery are rapidly converging to improve the customer/patient experience. 

Relying on tried and true approaches to strategy development may no longer be good enough when multiple markets collide. As health care delivery, payment, and reporting evolve in response to shifts in demographics, technology, and political influence, population health management becomes the key to controlling costs.

Read More

Topics: Fuld + Company, Market Analysis, Scenario Analysis, Technology/Telecomm, Healthcare, Industry Convergence, Competitive Strategy

New White Paper! Millennials: Predictors of Future Disruptions

Posted by Fuld + Company on Nov 5, 2015 12:35:05 PM

If you've been following us this past summer, you'll know Fuld + Company Founder Leonard Fuld spent some of those sunny days on the Rose Fitzgerald Kennedy Greenway. He was seeking insight into the minds of millennials, the demographic that will comprise 75% of the U.S. workforce in just 10 years. How did they feel about Uber, Amazon, and Obamacare? Were they shocked by Blackberry's demise? What did they want their weddings to look like?

The five surveys he conducted are now available in one white paper, Millennials: Predictors of Future Disruptions.

Read More

Topics: Brand Insights, Innovation, Market Analysis, Fuld, Leonard, Competitive Strategy

Pfizer’s Xeljanz: An Uphill Battle

Posted by Adi Reske on Oct 28, 2015 9:32:16 AM

Approx. 6 million people in the US have plaque psoriasisOn October 14th, 2015, Pfizer announced receipt of a Complete Response Letter (CRL) from the FDA regarding its recent supplemental New Drug Application (sNDA) for Xeljanz (tofacitinib) in moderate to severe plaque psoriasis.

The FDA accepted Pfizer’s filing in February 2015 based on data from the Phase III Oral treatment Psoriasis Trials (OPT) Program. A global, multi-study, clinical development program, OPT was designed to evaluate Xeljanz 5 mg and 10 mg twice daily in patients with the skin disorder.

Read More

Topics: Brand Insights, Market Analysis, Pharma, Life Sciences, Competitive Strategy

Dell Acquires EMC: Heavy Clouds, No Rain

Posted by Ken Sawka on Oct 27, 2015 12:06:53 PM


On October 12, Dell announced its plans to acquire EMC Corporation for $67 billion
, the largest technology industry deal to date, a deal clearly intended to bolster Dell’s ability to compete in the increasingly lucrative corporate data center market. This move follows HP’s split into two organizations which itself was engineered to free HP’s enterprise business from the low-margin shackles of its consumer PC and printer business.  While the Dell-EMC deal will accelerate the transition of corporate data assets to the cloud, the new entity could face significant challenges that hamper its ability to make it rain. 

Our experience conducting war games for Global Fortune 100 companies and analyzing competition in enterprise IT has made it clear that the market is undergoing a dramatic transformation. Our analysis, conducted over an extensive period of time and involving a variety of players, demonstrates that this transformation is characterized by several confluent factors that the combined EMC-Dell will have to navigate to achieve success: 

Read More

Topics: Competitive Intelligence, War Games, Brand Insights, Market Analysis, Technology/Telecomm, Merger and Acquisition

Jack Bauer and the Flu

Posted by Robert Flynn on Oct 23, 2015 6:49:12 AM

On February 5, 2015, Public Health England announced that the flu vaccine had demonstrated low effectiveness against the main strain of flu that had circulated this past winter. Dr. Michael Skinner of Imperial College London, said in response, “Trying to predict which seasonal flu vaccine to produce each year must be a bit like a Jack Bauer car chase in Los Angeles…bound to prove somewhat hit & miss.” 

A similar miss occurred in 2004, when the United States suspended The Chiron Corporation’s shipment of 48 million doses of vaccine, citing problems at the company’s Liverpool, England, manufacturing plant.

Read More

Topics: Brand Insights, Market Analysis, Pharma, Scenario Analysis, Healthcare, Life Sciences, Merger and Acquisition

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.